Author details

Full Name

Xing Guo

Affiliation

Life Sciences Institute, Zhejiang University

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

Andrej Sali (CM4AI)

PMID	Paper Title	Journal Title	Published Year
35989311	The ZSWIM8 ubiquitin ligase regulates neurodevelopment by guarding the protein quality of intrinsically disordered Dab1.	Cereb Cortex	2023
38019907	Lipid-anchored proteasomes control membrane protein homeostasis.	Sci Adv	2023
37848504	Chromosome-scale genomes of five Hongmu species in Leguminosae.	Sci Data	2023
37932434	Chromosome-level genomes of three key Allium crops and their trait evolution.	Nat Genet	2023
37978295	GDF11 slows excitatory neuronal senescence and brain ageing by repressing p21.	Nat Commun	2023
37214852	Lipid-anchored Proteasomes Control Membrane Protein Homeostasis.	bioRxiv	2023
37181047	Plant-on-chip: Core morphogenesis processes in the tiny plant <i>Wolffia australiana</i>.	PNAS Nexus	2023
37339966	The genome of Acorus deciphers insights into early monocot evolution.	Nat Commun	2023
36440598	Fine-tuning of mTOR signaling by the UBE4B-KLHL22 E3 ubiquitin ligase cascade in brain development.	Development	2022
34831298	Conserved Mitotic Phosphorylation of a Proteasome Subunit Regulates Cell Proliferation.	Cells	2021
33603165	Proteasome regulation by reversible tyrosine phosphorylation at the membrane.	Oncogene	2021
33762338	A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer.	Sci Adv	2021
33642574	The genome of Magnolia biondii Pamp. provides insights into the evolution of Magnoliales and biosynthesis of terpenoids.	Hortic Res	2021
34836973	Chloranthus genome provides insights into the early diversification of angiosperms.	Nat Commun	2021
32330457	Threonine ADP-Ribosylation of Ubiquitin by a Bacterial Effector Family Blocks Host Ubiquitination.	Mol Cell	2020
31843888	Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function.	Proc Natl Acad Sci U S A	2020
33191401	A small natural molecule CADPE kills residual colorectal cancer cells by inhibiting key transcription factors and translation initiation factors.	Cell Death Dis	2020
32668244	The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming.	Cell Rep	2020
30245026	CRL4<sup>DCAF2</sup> is required for mature T-cell expansion via Aurora B-regulated proteasome activity.	J Autoimmun	2019
29987021	Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.	Proc Natl Acad Sci U S A	2018
29039081	Proteasome dysregulation in human cancer: implications for clinical therapies.	Cancer Metastasis Rev	2017
28258412	Reversible phosphorylation of the 26S proteasome.	Protein Cell	2017
28292943	Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome.	Mol Cell Proteomics	2017
26940127	The 26S proteasome: A cell cycle regulator regulated by cell cycle.	Cell Cycle	2016
26655835	Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.	Nat Cell Biol	2016
25907364	A potent and selective inhibitor for the UBLCP1 proteasome phosphatase.	Bioorg Med Chem	2015
24012004	The EBAX-type Cullin-RING E3 ligase and Hsp90 guard the protein quality of the SAX-3/Robo receptor in developing neurons.	Neuron	2013
23849627	A P(E)RM(I)T for BMP signaling.	Mol Cell	2013
22785562	New secrets behind bone metastasis.	Cell Res	2012
23178113	A mediator lost in the war on cancer.	Cell	2012
21949367	UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity.	Proc Natl Acad Sci U S A	2011
19002158	Signaling cross-talk between TGF-beta/BMP and other pathways.	Cell Res	2009
18172167	Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.	Genes Dev	2008
18794144	The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.	Cancer Res	2008
18794808	Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.	Oncogene	2008
16227596	Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination.	Mol Cell Biol	2005
15133026	Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway.	J Biol Chem	2004

1 - 37 of 37

Alexandre Rosa Campos

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 2015

Number of shared co-authors 0

Min Gao

College of Horticulture, China Agricultural University

Career Start Year 2012

Number of shared co-authors 0

Florent Dingli

Institut Curie, PSL Research University

Career Start Year 2011

Number of shared co-authors 0

Rebecca S Levin

Howard Hughes Medical Institute, University of California San Francisco

Career Start Year 2010

Number of shared co-authors 0

Ai Kaiho

Tokyo Metropolitan Institute of Medical Science

Career Start Year 2008

Number of shared co-authors 2

Laura Pontano Vaites

Harvard Medical School

Career Start Year 2007

Number of shared co-authors 0

Genevi??ve Lavoie

Institute for Research in Immunology and Cancer (IRIC)

Career Start Year 2004

Number of shared co-authors 0

Min Liu

Xiamen University

Career Start Year 2004

Number of shared co-authors 0

Michael B Major

Washington University in St. Louis

Career Start Year 2004

Number of shared co-authors 0

Chunaram Choudhary

The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen

Career Start Year 2003

Number of shared co-authors 0

Judit Vill??n

University of Washington

Career Start Year 2001

Number of shared co-authors 0

Jeroen A A Demmers

Erasmus Medical Center

Career Start Year 2000

Number of shared co-authors 0

Jayantha Gunaratne

Institute of Molecular and Cell Biology

Career Start Year 2000

Number of shared co-authors 1

Rachel Toth

University of Dundee

Career Start Year 1999

Number of shared co-authors 1

Michael Rape

Howard Hughes Medical Institute, University of California at Berkeley

Career Start Year 1998

Number of shared co-authors 0

Rasmus Hartmann-Petersen

University of Copenhagen

Career Start Year 1998

Number of shared co-authors 0

Charles James Hastie

University of Dundee

Career Start Year 1998

Number of shared co-authors 1

Aaron Aslanian

Salk Institute for Biological Studies

Career Start Year 1998

Number of shared co-authors 0

James A Wohlschlegel

David Geffen School of Medicine, University of California Los Angeles

Career Start Year 1996

Number of shared co-authors 2

Damarys Loew

Institut Curie, PSL Research University

Career Start Year 1996

Number of shared co-authors 1

Matthias Gstaiger

Institute of Molecular Systems Biology, ETH Zurich

Career Start Year 1994

Number of shared co-authors 2

Brian Raught

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1994

Number of shared co-authors 2

Anne-Claude Gingras

Lunenfeld-Tanenbaum Research Institute

Career Start Year 1994

Number of shared co-authors 1

John Alan Diehl

Case Western Reserve University School of Medicine

Career Start Year 1993

Number of shared co-authors 0

Ivan Dikic

Institute of Biochemistry II, Goethe University Frankfurt

Career Start Year 1992

Number of shared co-authors 1

Steven P Gygi

Harvard Medical School

Career Start Year 1991

Number of shared co-authors 1

Peter K Jackson

Stanford University School of Medicine, Center for Clinical Sciences Research

Career Start Year 1989

Number of shared co-authors 1

Stephen J Elledge

Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School

Career Start Year 1982

Number of shared co-authors 0

J. Wade Harper

Harvard Medical School

Career Start Year 1981

Number of shared co-authors 1

Ze'ev Ronai

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 1981

Number of shared co-authors 1

row(s) 1 - 30 of 30

Jack E Dixon

University of California

Co-authored papers 8

Lan Huang

University of California Irvine

Co-authored papers 7

Xiaorong Wang

University of California Irvine

Co-authored papers 6

James L Engel

David Geffen School of Medicine, University of California los angeles

Co-authored papers 2

Ting Yang

College of Life Sciences, Sichuan University

Co-authored papers 2

Zhong-Yin Zhang

Center for Cancer Research, and Institute for Drug Discovery, Purdue University

Co-authored papers 1

Ruedi Aebersold

Institute of Molecular Systems Biology, ETH Zurich

Co-authored papers 1

Andrej Sali (CM4AI)

University of California San Francisco

Co-authored papers 1

Alexander Leitner

ETH Zurich

Co-authored papers 1

Eri Sakata

Max Planck Institute of Biochemistry

Co-authored papers 1

Alexander S Huszagh

University of California irvine

Co-authored papers 1

Kun-Liang Guan

University of California San Diego

Co-authored papers 1

Clinton Yu

University of California Irvine

Co-authored papers 1

Scott D Rychnovsky

University of California irvine

Co-authored papers 1

Abdullah Kahraman

University of Zurich

Co-authored papers 1

Paolo Nanni

Functional Genomics Center Zurich (FGCZ)-University of Zurich/ETH Zurich

Co-authored papers 1

Fuchou Tang

College of Life Sciences

Co-authored papers 1

Florian Beck

Max Planck Institute of Biochemistry

Co-authored papers 1

Yingying Yang

University of California irvine

Co-authored papers 1

Wolfgang Baumeister

Max Planck Institute of Biochemistry

Co-authored papers 1

Nikita Chopra

Schrodinger Inc.

Co-authored papers 1

Charles H Greenberg

University of California San Francisco

Co-authored papers 1

Jing Yang

University of California San Diego

Co-authored papers 1

Peter Cimermancic

Verily Life Sciences LLC

Co-authored papers 1

Anita B Hjelmeland

University of Alabama at Birmingham

Co-authored papers 1

Andreas Schweitzer

Max Planck Institute of Biochemistry

Co-authored papers 1

Eric J Novitsky

University of California irvine

Co-authored papers 1

Ping Xu

Co-authored papers 1

1 - 28

Author Details

Column Actions

Recommended Authors

Collaborators